Health care costs associated with Australian tertiary inflammatory bowel disease care

Scandinavian Journal of Gastroenterology
Belinda JacksonPeter De Cruz

Abstract

We aimed to describe the total costs of illness for IBD patients and compare the costs of patients with active disease to those with inactive disease. Resource use for IBD management was itemized for attributable costs (AUD) among all IBD patients over a 12-month period at an Australian hospital. One hundred and eighty-three patients were included (87 ulcerative colitis (UC); 93 Crohn's disease (CD); three IBD-unclassified). The median (IQR) annual overall cost was higher in the CD versus UC group ($15,648 versus $5017; p < .001). The difference in cost between CD and UC was influenced by the difference in outpatient costs for CD patients $9602 ($4311-$29,805) versus $4867 ($3220-$7249), p < .001). The cost of treating patients with active disease was $3461 ($1607-$11,771) and was higher in the CD versus the UC group ($6098 ($2168-$16,471) versus $1638 ($1401-$3767); p = .026) and was influenced by inpatient admissions. The cost of treating patients in remission was $2090 ($1552-$12,954) and was higher in the CD versus the UC group [$7977 ($1579-$14,304) versus $1848 ($1508-$6601); p = .236]. There is a discrepancy in costs of inpatient versus outpatient IBD management and treating active disease compared with disease in remiss...Continue Reading

References

Jun 1, 1992·Journal of Clinical Gastroenterology·J W Hay, A R Hay
Dec 17, 1997·Scandinavian Journal of Gastroenterology·P Blomqvist, A Ekbom
Aug 19, 2000·The American Journal of Gastroenterology·B G FeaganM V Bala
Aug 7, 2002·PharmacoEconomics·Keith Bodger
Nov 5, 2004·Australian Health Review : a Publication of the Australian Hospital Association·Jeff R J Richardson, Leonie Segal
Sep 9, 2005·European Journal of Gastroenterology & Hepatology·Derek P JewellScot Buchan
Dec 20, 2008·Health Economics·Michael K ChapkoMatthew L Maciejewski
Jan 8, 2010·Methods of Information in Medicine·John MantasUNKNOWN IMIA Recommendations on Education Task Force
Jan 29, 2011·PharmacoEconomics·Keith Bodger
Oct 2, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Tine JessJacob Simonsen
Oct 25, 2012·Digestive Diseases·Miles Parkes
Nov 9, 2012·Gut·Mirthe Emilie van der ValkUNKNOWN COIN study group and the Dutch Initiative on Crohn and Colitis
Jun 22, 2013·Alimentary Pharmacology & Therapeutics·A CroftG Radford-Smith
Oct 10, 2013·Health Services Research·Austin B Frakt
Oct 23, 2013·European Journal of Gastroenterology & Hepatology·Keith BodgerPaul Hodgkins
Nov 5, 2015·Public Health Research & Practice·Amalie DydaBette Liu
Apr 15, 2016·World Journal of Gastroenterology : WJG·Emily K WrightDanny Liew
Jul 1, 2015·Frontline Gastroenterology·Nivedita Ghosh, Purushothaman Premchand

❮ Previous
Next ❯

Citations

Jun 12, 2021·Alimentary Pharmacology & Therapeutics·Reinier Cornelis Anthonius van LinschotenRachel Louise West

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
Angela RocchiSubrata Ghosh
Inflammatory Bowel Diseases
Amnon Sonnenberg
© 2022 Meta ULC. All rights reserved